Patent | Date |
---|
Individualized Medicine Using Causal Models App 20220189632 - Brooks; Brian E. ;   et al. | 2022-06-16 |
Manufacturing A Biologic Pharmaceutical Using Causal Models App 20220178899 - Brooks; Brian E. ;   et al. | 2022-06-09 |
Adaptive Clinical Trials App 20220180979 - Brooks; Brian E. ;   et al. | 2022-06-09 |
Controlling Hospital Operations Using Causal Models App 20220172830 - Brooks; Brian E. ;   et al. | 2022-06-02 |
Treatment For Cutaneous T Cell Lymphoma App 20170340612 - ROOK; ALAIN H. ;   et al. | 2017-11-30 |
Methods And Compositions For Enhancing Immune Response App 20170319712 - MILLER; RICHARD L. ;   et al. | 2017-11-09 |
Methods and compositions for enhancing immune response Grant 9,801,947 - Miller , et al. October 31, 2 | 2017-10-31 |
Therapeutic Combinations And Methods Including Irm Compounds App 20150110784 - Tomai; Mark A. ;   et al. | 2015-04-23 |
Methods And Compositions For Enhancing Immune Response App 20150044279 - Miller; Richard L. ;   et al. | 2015-02-12 |
Therapeutic combinations and methods including IRM compounds Grant 8,940,755 - Tomai , et al. January 27, 2 | 2015-01-27 |
Treatment For Cutaneous T Cell Lymphoma App 20090246174 - Rook; Alain H. ;   et al. | 2009-10-01 |
Methods for the treatment of periodontal disease Grant 7,226,928 - Mitra , et al. June 5, 2 | 2007-06-05 |
Screening method for identifying compounds that selectively induce interferon alpha App 20060009482 - Tomai; Mark A. ;   et al. | 2006-01-12 |
Methods and compositions related to IRM compounds and toll-like receptor pathways App 20050245564 - Gorden, Keith B. ;   et al. | 2005-11-03 |
Enhancement of immune responses App 20050239735 - Miller, Richard L. ;   et al. | 2005-10-27 |
Therapeutic combinations and methods including IRM compounds App 20050226878 - Tomai, Mark A. ;   et al. | 2005-10-13 |
Therapeutic combinations and methods including IRM compounds App 20050171072 - Tomai, Mark A. ;   et al. | 2005-08-04 |
Immunomodulatory combinations App 20050158325 - Hammerbeck, David M. ;   et al. | 2005-07-21 |
Dye labeled imidazoquinoline compounds Grant 6,916,925 - Rice , et al. July 12, 2 | 2005-07-12 |
Neutrophil activation by immune response modifier compounds App 20050096259 - Tomai, Mark A. ;   et al. | 2005-05-05 |
Immunostimulatory combinations and treatments App 20050048072 - Kedl, Ross M. ;   et al. | 2005-03-03 |
Methods and compositions for enhancing immune response App 20040265351 - Miller, Richard L. ;   et al. | 2004-12-30 |
Immune response modifier compounds for treatment of TH2 mediated and related diseases App 20040242620 - Tomai, Mark A. ;   et al. | 2004-12-02 |
Immune response modifiers for the treatment of periodontal disease App 20040235881 - Mitra, Sumita B. ;   et al. | 2004-11-25 |
Immune response modifier compounds for treatment of TH2 mediated and related diseases Grant 6,696,076 - Tomai , et al. February 24, 2 | 2004-02-24 |
Methods and compositions related to IRM compounds and toll-like recptor pathways App 20040014779 - Gorden, Keith B. ;   et al. | 2004-01-22 |
Immune Response Modifier Compounds For Treatment Of Th2 Mediated And Related Diseases App 20030206868 - Tomai, Mark A. ;   et al. | 2003-11-06 |
Dye labeled imidazoquinoline compounds Grant 6,630,588 - Rice , et al. October 7, 2 | 2003-10-07 |
Maturation of dendritic cells with immune response modifying compounds App 20030186440 - Tomai, Mark A. ;   et al. | 2003-10-02 |
Immune response modifier compounds for treatment of TH2 mediated and related diseases Grant 6,610,319 - Tomai , et al. August 26, 2 | 2003-08-26 |
Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules App 20030133913 - Tomai, Mark A. ;   et al. | 2003-07-17 |
Maturation of dendritic cells with immune response modifying compounds Grant 6,558,951 - Tomai , et al. May 6, 2 | 2003-05-06 |
Dye labeled imidazoquinoline compounds App 20020120141 - Rice, Michael J. ;   et al. | 2002-08-29 |
Screening method for identifying compounds that selectively induce interferon alpha App 20020110840 - Tomai, Mark A. ;   et al. | 2002-08-15 |
Dye labeled imidazoquinoline compounds Grant 6,376,669 - Rice , et al. April 23, 2 | 2002-04-23 |
Immune response modifier compounds for treatment of TH2 mediated and related diseases App 20020041887 - Tomai, Mark A. ;   et al. | 2002-04-11 |
Gel formulations for topical drug delivery Grant 6,365,166 - Beaurline , et al. April 2, 2 | 2002-04-02 |
Gel Formulations For Topical Drug Delivery App 20020015715 - BEAURLINE, JOSEPH M. ;   et al. | 2002-02-07 |
Immine response modifier compounds for treatment of TH2 mediated and related diseases Grant 6,200,592 - Tomai , et al. March 13, 2 | 2001-03-13 |
1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants Grant 6,083,505 - Miller , et al. July 4, 2 | 2000-07-04 |
Immune response modifier compounds for treatment of TH2 mediated and related diseases Grant 6,039,969 - Tomai , et al. March 21, 2 | 2000-03-21 |
Gel formulations for topical drug delivery Grant 5,939,090 - Beaurline , et al. August 17, 1 | 1999-08-17 |